Cancer survival in England: adult, stage at diagnosis and childhood - patients followed up to 2021

Product Description

This release summarises the survival of adults diagnosed with cancer in England between 2016 and 2020 and followed to 2021, and children diagnosed with cancer in England between 2002 and 2020 and followed to 2021. Adult cancer survival estimates are presented by age, deprivation, gender, stage at diagnosis, and geography.

• Cancer survival is highest for melanoma of the skin and cancer of the testis
  1-year survival is highest for melanoma for both males (97.3%) and females (98.6%). 5-year survival is highest for cancer of the testis in males (93.5%) and for melanoma in females (94.6%).
• Cancer survival is lowest for pancreatic cancer
  1-year survival is lowest for pancreatic cancer for both males (27.4%) and females (28.1%). 5-year survival is lowest for pancreatic cancers for both males (8.4%) and females (8.2%).
• Cancer survival is lower in areas with higher deprivation
  For most cancers, the survival decreases consistently for each deprivation quintile from least deprived to most deprived.
• Cancer survival varies by stage at diagnosis
  5-year survival by stage ranges from 3.5% (stage 4 lung cancer for males) to 101.1% (stage 1 melanoma for females). Childhood cancer survival continues to improve With 5-year survival seeing the greatest improvement over time, from 77.8% in 2002 to 86.2% in 2020.